Radionuclide therapy of pheochromocytomas and neuroblastomas using iodine-131 metaiodobenzylguanidine (MIBG)
- PMID: 2714036
- DOI: 10.1097/00003072-198901000-00006
Radionuclide therapy of pheochromocytomas and neuroblastomas using iodine-131 metaiodobenzylguanidine (MIBG)
Similar articles
-
The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.Q J Nucl Med. 1995 Dec;39(4 Suppl 1):55-7. Q J Nucl Med. 1995. PMID: 9002750
-
[131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].Rinsho Hoshasen. 1987 Apr;32(4):461-70. Rinsho Hoshasen. 1987. PMID: 3613180 Japanese. No abstract available.
-
Applications of [131I]m-iodobenzylguanidine ([131I]MIBG).Int J Rad Appl Instrum B. 1987;14(3):183-9. doi: 10.1016/0883-2897(87)90041-9. Int J Rad Appl Instrum B. 1987. PMID: 3312118 Review.
-
[Therapy of malignant pheochromocytoma using I-131 metaiodobenzylguanidine--report of a case].Nihon Igaku Hoshasen Gakkai Zasshi. 1990 Mar 25;50(3):286-94. Nihon Igaku Hoshasen Gakkai Zasshi. 1990. PMID: 2345700 Japanese.
-
[Iodine-131 meta-iodobenzylguanidine for the diagnosis and treatment of pheochromocytoma and tumors of neural crest origin].Harefuah. 1992 Apr 15;122(8):526-9. Harefuah. 1992. PMID: 1398325 Review. Hebrew. No abstract available.
Cited by
-
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma.Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD010349. doi: 10.1002/14651858.CD010349.pub2. Cochrane Database Syst Rev. 2017. PMID: 28429876 Free PMC article. Review.
-
The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.J Endocrinol Invest. 1997 Dec;20(11):648-58. doi: 10.1007/BF03348026. J Endocrinol Invest. 1997. PMID: 9492103 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical